The two most prevalent respiratory diseases, asthma and COPD, affect more than 480 million people worldwide. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the markets for airway management accessories (HMEs, humidifiers, large- and small-volume nebulizers, nebulizer compressors, and respiratory masks) and sleep apnea products (OSA monitors and therapy devices, and polysomnographs) for the US, the five major EU markets, Japan, and the rest of world markets.
The combined global market for airway management accessories and sleep apnea products totaled nearly $7.2bn in 2017, and is expected to climb at a rate of 7.4% over the forecast period covered by this analysis. Sleep apnea products accounted for nearly 70% of total sales. Within the sleep apnea products market, OSA therapy devices accounted for an estimated 84% of sales. Four companies (Philips Healthcare, ResMed, Drive - DeVilbiss, and Vyaire Medical) hold more than two-thirds of the total market.
Key Questions Answered:
- What are the key drivers and limiters to the global airway management accessories and sleep apnea products markets?
- Which competitors are leading the market and introducing new technology?
- How are technological advancements impacting market growth?
- How are mergers and acquisitions affecting the markets shares of leading competitors?
Table of Contents
Companies Mentioned
- Drive - DeVilbiss
- Philips Healthcare
- ResMed
- Vyaire Medical
